
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Himalaya Nutravedics India Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.

Price Band
₹106
Per Share
Lot Size
1200 Shares

Minimum Investment
₹1,27,200

Issue Size
₹26.5 Cr

Face Value
₹10
Per Share
IPO Type
Book Building - SME

Retail Quota
35.08%

QIB Quota
49.9%

NII Quota
15.02%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
95.14%
Promoter Holding (Post-Issue)
68.13%
Issue Type
Book Building - SME
ISIN
INE1OTR01013
Our Company, Himalaya Nutravedics India Limited (the "Company"), is engaged in the manufacture, marketing and distribution of Ayurvedic and Nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and Nutraceutical companies. Our Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, which are based on compositions and processes described in traditional Ayurvedic texts, proprietary Ayurvedic formulations and Nutraceutical products across multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, Liquid orals, Medicated oils.
Our Company was originally incorporated and registered as a private limited company under the Companies Act, 2013 under the name of `Himalaya Nutravedics India Private Limited' on June 16, 2022 bearing Corporate Identification Number U24110TG2022PTC163732 Issued by the Registrar of Companies, Central Registration Centre. Thereafter, our Company was converted into a public limited company pursuant to a special resolution passed by our members at the Extra Ordinary General Meeting held on November 28, 2025 and consequently the name of our Company was changed to `Himalaya Nutravedics India Limited'. A fresh certificate of incorporation consequent upon conversion from private limited company to public limited company dated December 12, 2025, was issued by Registrar of Companies, Central Processing Centre bearing Corporate Identification Number U24110TG2022PLC163732.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public issue of upto 24,99,600 equity shares of face value of Rs. 10/- each ("Equity Shares") of the company at an issue price of Rs. 106 per equity share (including a share premium of Rs. 96 per equity share) for cash, aggregating up to Rs. 26.50 Crores ("Public Issue"), out of which 1,26,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 106 per equity share for cash, aggregating Rs. 1.34 Crores was reserved for subscription by the market maker to the issue ( the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of up to 23,73,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. 106 per equity share for cash, aggregating up to Rs. 25.16 Crores is hereinafter referred to as the "Net Issue". The issue and net issue will constitute 28.38% and 26.95% respectively of the post issue paid-up equity share capital of the company. Price Band: Rs. 106 per equity share of face value of Rs. 10/- each. The floor price is 10.6 times the face value of the equity shares. Bids can be made for a minimum of 2400 equity shares and in multiples of 1200 equity shares.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.